DataKnowledgeCloudtrainingcoordination

L1000 LINCS DCIC REP.A028 HA1E 24H E23 tadalafil 0.125uM.tsv.gz (File)

Taxon:

Homo sapiens

Taxon (Entity type)

Subject:

HA1E

Subject (Entity type)

Project:

LINCS-2021

Project (Entity type)

File Format:

TSV

File Format (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Data Type:

gene expression profile

Data Type (Entity type)

Compression Format:

GZIP format

File Format (Entity type)

Biosample:

L1000 LINCS DCIC 2021 REP.A028 HA1E 24H E23 tadalafil 0.125uM

Biosample (Entity type)

Assay Type:

landmark transcript profiling assay

Assay Type (Entity type)

Anatomy:

kidney

Anatomy (Entity type)

Uncompressed Size In Bytes:756 KB

Size In Bytes:281 KB

Sha256:49b074e7472be9bdd2fb4fe0ce066b3af1d245fff814e9ca0197d24030f98a8d

Persistent Id:drs://drs.lincs-dcic.org/b2b003166ce82a088b8bfbd57c1f0d80

Mime Type:application/gzip

Md5:b2b003166ce82a088b8bfbd57c1f0d80

Filename:L1000_LINCS_DCIC_REP.A028_HA1E_24H_E23_tadalafil_0.125uM.tsv.gz

Creation Time:2021-01-21T00:00:00

Access Url:

drs://drs.lincs-dcic.org/b2b003166ce82a088b8bfbd57c1f0d80

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 REP.A028 HA1E 24H E23 tadalafil 0.125uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 REP.A028 HA1E 24H E23 tadalafil 0.125uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.